AKAnusha Krishnadasan

Anusha Krishnadasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anusha Krishnadasan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pilot Randomized Trial of Patient-Directed vs Fixed-Antibiotic Duration in Acute Pyelonephritis

    by Brett Faine, Gregory Moran, Anusha Krishnadasan, Anne Zepeski, Ruoyu Li, William Mower, Scott Evans, Jesus Torres, Frank LoVecchio, Nicholas Mohr, et al.

    In this multicenter double-blind pilot randomized trial, patient-directed antibiotic duration after symptom resolution demonstrated similar sustained clinical resolution and adverse events compared to fixed-duration treatment among women with pyelonephritis. These findings support the feasibility of this strategy and justify a larger, adequately powered randomized trial to evaluate efficacy and safety. Pyelonephritis; patient-directed antibiotic duration

  • Open Access

    Performance and Projected Impact of Synovial Fluid Polymerase Chain Reaction Testing for Patients Evaluated for Septic Arthritis

    by Mark T Steele, Amy M Stubbs, Anusha Krishnadasan, Laurie Kemble, Ruoyu Li, William R Mower, Joseph Liao, Gregory J Moran, David A Talan, Danielle Beckham, et al.

    Background: Septic arthritis is an infectious disease emergency. Diagnosis is limited by low sensitivity of synovial fluid cell count and Gram stain and delayed culture results. The impact of polymerase chain reaction (PCR) testing on clinical care of patients suspected of septic arthritis is unknown. Methods: We conducted a prospective, observational study (2021–2023) at 9 US emergency departments (EDs) of adults evaluated for septic arthritis with synovial fluid culture and subsequent PCR testing of residual fluid. We report PCR concordance, sensitivity, and specificity compared to culture, 30-day diagnosis, and antibiotic delay >1 day and project the impact of point-of-care PCR results. Results: Of 475 participants, 126 (26.5%) were diagnosed with septic arthritis. Eighty-eight (18.5%) had positive PCR and 80 (16.8%) had positive culture that identified, respectively, Staphylococcus aureus (36 [40.9%] vs 29 [36.3%]), streptococci (32 [36.4%] vs 22 [27.5%]), and Neisseria gonorrhoeae (12 [13.6%] vs 4 [5.0%]). PCR-culture concordance was 89.5%. For PCR-targeted organisms, PCR sensitivity and specificity were 89.2% (95% confidence interval [CI], 79.4%–94.7%) and 95.3% (95% CI, 92.5%–97.1%), respectively. Fifty-seven (45.2%) participants with septic arthritis had concordant positive PCR/culture results; 11 (19.3%) had delayed treatment (1–6 days). Nineteen (15.1%) participants with septic arthritis had a PCR-positive/culture-negative result, which occurred more frequently with antibiotic pretreatment and N. gonorrhoeae; all were treated empirically. Three participants with only PCR-detected N. gonorrhoeae did not receive treatment for the infection. Conclusions: Adjunctive point-of-care PCR testing is projected to improve the timeliness of ED septic arthritis diagnosis and pathogen-specific treatment. Clinical Trials Registration: NCT05341908

  • Differential Odds of COVID-19 Infection Associated With Household and Workplace Exposures in US Health Care Personnel

    by Eric Kontowicz, Amanda K. Irish, Ian D. Plumb, Melissa Briggs-Hagen, Karisa K. Harland, Anusha Krishnadasan, David A. Talan, Patrick Ten Eyck, Mark T. Steele, Efrat R. Kean, et al.

    Objective: The aim of the study was to evaluate associations between occupational and nonoccupational COVID-19 exposures, household characteristics, and COVID-19 infection risk among health care personnel (HCP). Methods: This is a nested analysis of HCP enrolled in a multisite vaccine effectiveness study. COVID-19 infection was confirmed through source documentation. Exposures and household characteristics were self-reported. Results: HCP with household COVID-19 exposure had significantly higher infection odds, while workplace exposure was associated with decreased odds of infection. No associations were observed for community exposures, living with children, or living with unvaccinated household members. Conclusions: Household exposure posed greater COVID-19 risk to HCP unlike exposures in the workplace. Combined with demonstrated vaccine effectiveness, these findings suggest that workplace infection control measures were successful, while interventions targeting household transmission may be critical for protecting HCP.